Tammy S Jacobs1, Erick Forno1, John M Brehm1, Edna Acosta-Pérez2, Yueh-Ying Han1, Joshua Blatter1, Peter Thorne3, Nervana Metwali3, Angel Colón-Semidey2, María Alvarez2, Glorisa Canino2, Juan C Celedón4. 1. Division of Pediatric Pulmonary Medicine, Allergy and Immunology, Children's Hospital of Pittsburgh of University of Pittsburgh, Pittsburgh, Pennsylvania. 2. Behavioral Sciences Research Institute, University of Puerto Rico, San Juan, Puerto Rico. 3. Department of Occupational and Environmental Health, University of Iowa College of Public Health, University of Iowa, Iowa City, Iowa. 4. Division of Pediatric Pulmonary Medicine, Allergy and Immunology, Children's Hospital of Pittsburgh of University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: juan.celedon@chp.edu.
Abstract
BACKGROUND: Little is known about exposure to mouse allergen (Mus m 1) and allergic rhinitis (AR). OBJECTIVE: To evaluate the association between mouse allergen exposure and AR in children. METHODS: We examined the relation between mouse allergen level in house dust and AR in 511 children aged 6 to 14 years in San Juan, Puerto Rico. Study participants were chosen from randomly selected households using a multistage probability sample design. The study protocol included questionnaires, allergy skin testing, and collection of blood and dust samples. AR was defined as current rhinitis symptoms and skin test reactivity to at least one allergen. RESULTS: In the multivariate analyses, mouse allergen level was associated with a 25% decreased odds of AR in participating children (95% confidence interval, 0.62-0.92). Although endotoxin and mouse allergen levels were significantly correlated (r = 0.184, P < .001), the observed inverse association between Mus m 1 and AR was not explained by levels of endotoxin or other markers of microbial or fungal exposure (peptidoglycan and glucan). CONCLUSION: Mouse allergen exposure is associated with decreased odds of AR in Puerto Rican school-aged children.
BACKGROUND: Little is known about exposure to mouse allergen (Mus m 1) and allergic rhinitis (AR). OBJECTIVE: To evaluate the association between mouse allergen exposure and AR in children. METHODS: We examined the relation between mouse allergen level in house dust and AR in 511 children aged 6 to 14 years in San Juan, Puerto Rico. Study participants were chosen from randomly selected households using a multistage probability sample design. The study protocol included questionnaires, allergy skin testing, and collection of blood and dust samples. AR was defined as current rhinitis symptoms and skin test reactivity to at least one allergen. RESULTS: In the multivariate analyses, mouse allergen level was associated with a 25% decreased odds of AR in participating children (95% confidence interval, 0.62-0.92). Although endotoxin and mouse allergen levels were significantly correlated (r = 0.184, P < .001), the observed inverse association between Mus m 1 and AR was not explained by levels of endotoxin or other markers of microbial or fungal exposure (peptidoglycan and glucan). CONCLUSION:Mouse allergen exposure is associated with decreased odds of AR in Puerto Rican school-aged children.
Authors: Catarina Almqvist; Frances Garden; Andrew S Kemp; Qiang Li; Daniel Crisafulli; Euan R Tovey; Wei Xuan; Guy B Marks Journal: Paediatr Perinat Epidemiol Date: 2010-03 Impact factor: 3.980
Authors: Elizabeth C Matsui; Peyton A Eggleston; Patrick N Breysse; Cynthia S Rand; Gregory B Diette Journal: J Allergy Clin Immunol Date: 2007-03-02 Impact factor: 10.793
Authors: Robin S Everhart; Sheryl J Kopel; Cynthia A Esteban; Elizabeth L McQuaid; Robert Klein; Christine E McCue; Daphne Koinis-Mitchell Journal: Ann Allergy Asthma Immunol Date: 2014-02-28 Impact factor: 6.347
Authors: Kathleen M Donohue; Umaima Al-alem; Matthew S Perzanowski; Ginger L Chew; Alina Johnson; Adnan Divjan; Elizabeth A Kelvin; Lori A Hoepner; Frederica P Perera; Rachel L Miller Journal: J Allergy Clin Immunol Date: 2008-11 Impact factor: 10.793
Authors: Erick Forno; Mudita Gogna; Alfonso Cepeda; Anahi Yañez; Dirceu Solé; Philip Cooper; Lydiana Avila; Manuel Soto-Quiros; Jose A Castro-Rodriguez; Juan C Celedón Journal: Thorax Date: 2015-06-23 Impact factor: 9.139
Authors: Cynthia A Esteban; Robin S Everhart; Sheryl J Kopel; Robert B Klein; Daphne Koinis-Mitchell Journal: Ann Allergy Asthma Immunol Date: 2017-09 Impact factor: 6.347
Authors: Ahmad R Sedaghat; Elizabeth C Matsui; Sachin N Baxi; Mary E Bollinger; Rachel Miller; Matthew Perzanowski; Wanda Phipatanakul Journal: J Allergy Clin Immunol Pract Date: 2015-10-02